Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Planned sale CFO and Treasurer sold 10,000 shares at $99.36 ($993,600)
  2. 4 Grant or award Director acquired 2,012 shares (grant or award)
  3. 4 Grant or award Director acquired 2,012 shares (grant or award)
  4. 4 Grant or award Director acquired 2,012 shares (grant or award)
  5. 4 Grant or award Director acquired 2,012 shares (grant or award)
  6. 4 Grant or award Director acquired 2,012 shares (grant or award)
  7. 4 Grant or award Director acquired 2,012 shares (grant or award)
  8. 4 Grant or award Director acquired 2,012 shares (grant or award)
  9. 4 Grant or award Director acquired 2,012 shares (grant or award)
  10. 4 Planned sale See Remarks sold 6,113 shares at $98.82 ($604,087)
  11. 4 Grant or award See Remarks acquired 8,464 shares (grant or award)
  12. 4 Planned sale Chief Accounting Officer sold 386 shares at $88.67 ($34,227)
  13. 4 Grant or award See Remarks acquired 3,301 shares (grant or award)
  14. 4 Planned sale Chief Business Officer sold 2,118 shares at $88.67 ($187,803)
  15. 4 Planned sale Chief Business Officer sold 3,684 shares at $82.09 ($302,420)
  16. 4/A Open-market sale CEO sold 44,484 shares at an average $80.77 ($3,592,856)
  17. 4 Open-market sale Director sold 13,290 shares at $81.13 ($1,078,218)
  18. 4 Open-market sale CEO sold 44,484 shares at an average $80.77 ($3,592,856)
  19. 4 Open-market sale Chief Business Officer sold 14,528 shares at $81.13 ($1,178,657)
  20. 4 Open-market sale Director sold 7,012 shares at an average $80.75 ($566,200)

Page 9 of 30 · 598 filings